ApoA2 may be associated with a similar risk in mouse vasculitis models because it is one of the target antigens of VasSF, which has been developed as a novel antibody drug, derived from IgG, for vasculitis in SCG/Kj mouse [12]. The gene discussed is APOA2; the disease is vasculitis.